Umbra Applied Technologies Group, Inc. announced that it has delivered the first shipment of Hygieia™ antimicrobial inserts to NextCast & Brace for their production run prototypes of their advanced casting system. This signals the beginning of a five-year contract with their new strategic medical devices partner. The strategic partnership between Umbra Applied technologies and NextCast & Brace is in keeping with UAT’s focus on expansion through strategic partnerships and value-add growth management. The Company continues to field inquiries and is currently in negotiations with other companies interested in partnering with UAT. The company also confirmed rumors that it has expanded its manufacturing and distribution relationships which it anticipates being fully online within the coming weeks. Additionally, the Company has expanded its inventory management and fulfillment capabilities by adding an additional warehouse and office location in Hudson Florida. This was done in preparation for the upcoming holiday season which the company anticipates will be a significant revenue driver. The Hygieia™ line of products, which is expected to grow to more than nine products with multiple versions and colors, is poised to deliver significant revenues by year end. The company further outlined its strategy to expand its Biotech division with the release of its acclaimed ClearView® bone fixation system to include its revolutionary new titanium Aegis™ surgical bone pin. The company added that it anticipates the release of the Apex™ interphalangeal implant around the same time as the ClearView® product in the first quarter of 2019. This is the most significant expansion of the UAT Biotech division since the launch of the Hygieia™ product line.